<?xml version="1.0" encoding="UTF-8"?>
<results title="funders">
 <result pre="editing2*[1], Center of Excellence in Clinical Virology, Department of Pediatrics," exact="Faculty of Medicine, Chulalongkorn University," post="Bangkok, Thailand[2], Department of Infectious Diseases, St. Jude Children’s"/>
 <result pre="Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine," exact="Chulalongkorn University," post="Bangkok, Thailand[2], Department of Infectious Diseases, St. Jude Children’s"/>
 <result pre="Children’s Research Hospital, Memphis, Tennessee, United States of AmericaTompkinsStephen MarkEditor[]," exact="University of Georgia," post="UNITED STATES Competing Interests: The NAIs oseltamivir carboxylate (oseltamivir)"/>
 <result pre="and should be empirically determined. Funding http://dx.doi.org/10.13039/100006492Division of Intramural Research," exact="National Institute of Allergy and Infectious Diseases" post="HHSN272201400006CWebbyRichard J. National Science and Technology Development Agency ThailandP-15-50004PoovorawanYong"/>
 <result pre="Research, National Institute of Allergy and Infectious Diseases HHSN272201400006CWebbyRichard J." exact="National Science and Technology Development Agency" post="ThailandP-15-50004PoovorawanYong The Center of Excellence in Clinical Virology of"/>
 <result pre="This work was supported by the following funding sources: The" exact="National Institute of Allergy and Infectious Diseases," post="National Institutes of Health, Centers of Excellence for Influenza"/>
 <result pre="funding sources: The National Institute of Allergy and Infectious Diseases," exact="National Institutes of Health," post="Centers of Excellence for Influenza Research and Surveillance (CEIRS)"/>
 <result pre="Syrian Associated Charities (ALSAC), The Research Chair Grant from the" exact="National Science and Technology Development Agency" post="(P-15-50004) to Yong Poovorawan, and The Center of Excellence"/>
 <result pre="Poovorawan, and The Center of Excellence in Clinical Virology of" exact="Chulalongkorn University" post="(GCE 59-009-30-005) to Yong Poovorawan. Nipaporn Tewawong received the"/>
 <result pre="received the Overseas Research Experience Scholarship for Graduate Students of" exact="Chulalongkorn University." post="The funders had no role in study design, data"/>
 <result pre="zanamivir, and intravenous peramivir, are approved by the United States" exact="Food and Drug Administration" post="and are recommended for the prophylaxis and treatment of"/>
 <result pre="obtained from the Center of Excellence in Clinical Virology at" exact="Chulalongkorn University" post="in Thailand as part of the influenza surveillance program."/>
 <result pre="Institutional Review Board (IRB) of the Faculty of Medicine at" exact="Chulalongkorn University" post="(IRB No. 581/58). The study was conducted according to"/>
 <result pre="(Birmingham, AL). References References 1FioreAE, FryA, ShayD, GubarevaL, BreseeJS, UyekiTM;" exact="Centers for Disease Control and Prevention" post="(CDC). Antiviral agents for the treatment and chemoprophylaxis of"/>
 <result pre="of influenza B neuraminidase and its complex with sialic acid." exact="EMBO" post="J. 1992; 11(1):49–56. 1740114 8ColmanPM, HoynePA, LawrenceMC. Sequence and"/>
</results>
